Dichotomous location of 160 atypical femoral fractures
暂无分享,去创建一个
[1] J. Schilcher,et al. Atypical fractures do not have a thicker cortex , 2012, Osteoporosis International.
[2] R. Stern,et al. Atypical femoral fracture following bisphosphonate treatment in a woman with osteogenesis imperfecta—a case report , 2012, Acta orthopaedica.
[3] A. Boskey,et al. Atypical subtrochanteric femoral shaft fractures: role for mechanics and bone quality , 2012, Arthritis Research & Therapy.
[4] A. Rydholm. Highly different risk estimates for atypical femoral fracture with use of bisphosphonates – debate must be allowed! , 2012, Acta orthopaedica.
[5] A. Reigstad,et al. Atypical fracture of the ulna associated with alendronate use , 2011, Acta orthopaedica.
[6] S. Ott,et al. Utility of automated data in identifying femoral shaft and subtrochanteric (diaphyseal) fractures , 2011, Osteoporosis International.
[7] T. Brown,et al. Erratum: Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the American Society for Bone and Mineral Research (Journal of Bone and Mineral Research (2010) 25 (2267-2294)) , 2011 .
[8] M. Tan,et al. Bisphosphonate-associated atypical fracture of the femur: Spontaneous healing with drug holiday and re-appearance after resumed drug therapy with bilateral simultaneous displaced fractures — a case report , 2011, Acta orthopaedica.
[9] T. Howe,et al. Distribution of atypical fractures and cortical stress lesions in the femur: implications on pathophysiology. , 2011, Singapore medical journal.
[10] Klaus Klaushofer,et al. Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[11] I. McNamara,et al. Classification of subtrochanteric femoral fractures. , 2010, Injury.
[12] S. Cummings,et al. Effect of Once-Yearly Zoledronic Acid Five Milligrams on Fracture Risk and Change in Femoral Neck Bone Mineral Density , 2010 .
[13] S. Cummings,et al. Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density. , 2009, The Journal of clinical endocrinology and metabolism.
[14] A. Phillips. The femur as a musculo-skeletal construct: a free boundary condition modelling approach. , 2009, Medical engineering & physics.
[15] S. Cummings,et al. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. , 2006, JAMA.
[16] J. O'Connor,et al. Strain distribution within the human femur due to physiological and simplified loading: Finite element analysis using the muscle standardized femur model , 2003, Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine.
[17] Adrian E. Raftery,et al. Model-Based Clustering, Discriminant Analysis, and Density Estimation , 2002 .
[18] S. Cummings,et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.
[19] Robert W. Bucholz,et al. The Comprehensive Classification of Fractures of Long Bones. , 1991 .
[20] John C. Koch,et al. The laws of bone architecture , 1917 .
[21] J. Ranstam,et al. Atypical femoral fractures are a separate entity, characterized by highly specific radiographic features. A comparison of 59 cases and 218 controls. , 2013, Bone.
[22] M. Swiontkowski,et al. Bisphosphonate Use and Atypical Fractures of the Femoral Shaft , 2012 .
[23] Adrian E. Raftery,et al. mclust Version 4 for R : Normal Mixture Modeling for Model-Based Clustering , Classification , and Density Estimation , 2012 .
[24] J. Dungan. Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur , 2011 .
[25] W. Taylor,et al. Physiologically based boundary conditions in finite element modelling. , 2007, Journal of biomechanics.